Funded Tech Companies

ORIC Pharmaceuticals

ORIC Pharmaceuticals is a leading biopharmaceutical venture, based in South San Francisco. Venture investment and financing was provided by Taiho Ventures, Fidelity Management & Research Company and OrbiMed.

Company Overview

Contact Information

Company Background Information

Overview

ORIC Pharmaceuticals Nasdaq: ORIC) is dedicated to discovering and developing novel therapies for treatment-resistant cancers. While recent advances with targeted therapeutics have extended prognoses in many disease settings, cancers often develop resistance to current drugs.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/23/2020

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jacob Chacko

        

Chief Financial Officer

Dominic Piscitelli

        

Chief Medical Officer

Pratik Multani

        

Chief Scientific Officer

Lori Friedman

        

Vice President

Edna Maneval

        

VP - Bus. Development

Matthew Panuwat

        

VP - General Counsel

Christian Kuhlen

        

Company Investors

• Taiho Ventures
• Fidelity Management & Research Company
• OrbiMed
• Topspin Partners
• KKR
• Trinitas Capital
• The Column Group (Peter Svennilson)
• NS Investment
• Foresite Capital
• EcoR1 Capital Management
• Memorial Sloan Kettering Cancer Center

Browse more funded tech companies:

Ori | OriCell Therapeutics

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary